Screening adult survivors of childhood cancer for cardiomyopathy: Comparison of echocardiography and cardiac magnetic resonance imaging

Journal of Clinical Oncology

Volumn 30, Issue 23, 2012, Pages 2876-2884

  Armstrong, Gregory T ^a   Plana, Juan Carlos ^d   Zhang, Nan ^a   Srivastava, Deokumar ^a   Green, Daniel M ^a   Ness, Kirsten K ^a   Donovan, F Daniel ^b   Metzger, Monika L ^a   Arevalo, Alejandro ^c   Durand, Jean Bernard ^e   Joshi, Vijaya ^c   Hudson, Melissa M ^a   Robison, Leslie L ^a   Flamm, Scott D ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Methodist Hospitals of Memphis   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EWING SARCOMA; FALSE NEGATIVE RESULT; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART SIZE; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; RADIOTHERAPY; SURVIVORS; YOUNG ADULT;

EID: 84865092873     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.3584     Document Type: Article

References (23)

1. Ries LA, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2005. Bethesda, MD, National Cancer Institute, 2008. http://seer.cancer. gov/csr/1975-2005/
2. Mertens AC, Liu Q, Neglia JP, et al: Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
3. Mariotto AB, Rowland JH, Yabroff KR, et al: Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18:1033-1040, 2009
4. van der Pal HJ, van Dalen EC, Hauptmann M, et al: Cardiac function in 5-year survivors of childhood cancer: A long-term follow-up study. Arch Intern Med 170:1247-1255, 2010
5. Lipshultz SE, Vlach SA, Lipsitz SR, et al: Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics 115:1613-1622, 2005
6. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
7. Hudson MM, Rai SN, Nunez C, et al: Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol 25:3635-3643, 2007
8. Hull MC, Morris CG, Pepine CJ, et al: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831-2837, 2003
9. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004
10. Bellenger NG, Burgess MI, Ray SG, et al: Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: Are they interchangeable? Eur Heart J 21:1387-1396, 2000
11. American College of Cardiology Foundation Task Force on Expert Consensus Documents, Hundley WG, Bluemke DA, et al: ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2614-2662, 2010
12. Constantine G, Shan K, Flamm SD, et al: Role of MRI in clinical cardiology. Lancet 363:2162-2171, 2004
13. Lima JA, Desai MY: Cardiovascular magnetic resonance imaging: Current and emerging applications. J Am Coll Cardiol 44:1164-1171, 2004
14. Grothues F, Smith GC, Moon JC, et al: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90:29-34, 2002
15. Hudson MM, Ness KK, Nolan VG, et al: Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 56:825-836, 2011
16. Alfakih K, Plein S, Thiele H, et al: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17:323-329, 2003
17. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463, 2005
18. Lima JA, Judd RM, Bazille A, et al: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: Potential mechanisms. Circulation 92:1117-1125, 1995
19. Pennell DJ, Sechtem UP, Higgins CB, et al: Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940-1965, 2004
20. Mulrooney DA, Yeazel MW, Kawashima T, et al: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606, 2009
21. Lipshultz SE, Lipsitz SR, Sallan SE, et al: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636, 2005
22. Centers for Medicare and Medicaid Services: Overview. http://www.cms.gov/apps/physician-fee-schedule/
23. [No authors listed]: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: The SOLVD Investigators. N Engl J Med 327:685-691, 1992